43:I[58016,["/_next/static/chunks/0e29vbidvogc6.js","/_next/static/chunks/09md0.811p4qk.js","/_next/static/chunks/0jjo8hz~ewue4.js","/_next/static/chunks/084k0pvimg.lq.js","/_next/static/chunks/0a~e7k..h6jfc.js","/_next/static/chunks/0d1e9m2ig9v3v.js","/_next/static/chunks/0dzini03ngxm2.js","/_next/static/chunks/0rizq9ux3s1w3.js","/_next/static/chunks/139o5utivfajl.js","/_next/static/chunks/0i-f~c821e7uk.js","/_next/static/chunks/0z7avafhgjcyr.js"],"ProcessEpisodeButton"] 45:I[185,["/_next/static/chunks/0e29vbidvogc6.js","/_next/static/chunks/09md0.811p4qk.js","/_next/static/chunks/0jjo8hz~ewue4.js","/_next/static/chunks/084k0pvimg.lq.js","/_next/static/chunks/0a~e7k..h6jfc.js","/_next/static/chunks/0d1e9m2ig9v3v.js","/_next/static/chunks/0dzini03ngxm2.js","/_next/static/chunks/0rizq9ux3s1w3.js","/_next/static/chunks/139o5utivfajl.js","/_next/static/chunks/0i-f~c821e7uk.js","/_next/static/chunks/0z7avafhgjcyr.js"],"SendEmailButton"] 46:I[45269,["/_next/static/chunks/0e29vbidvogc6.js","/_next/static/chunks/09md0.811p4qk.js","/_next/static/chunks/0jjo8hz~ewue4.js","/_next/static/chunks/084k0pvimg.lq.js","/_next/static/chunks/0a~e7k..h6jfc.js","/_next/static/chunks/0d1e9m2ig9v3v.js","/_next/static/chunks/0dzini03ngxm2.js","/_next/static/chunks/0rizq9ux3s1w3.js","/_next/static/chunks/139o5utivfajl.js","/_next/static/chunks/0i-f~c821e7uk.js","/_next/static/chunks/0z7avafhgjcyr.js"],"SignupCTA"] 48:I[56939,["/_next/static/chunks/0e29vbidvogc6.js","/_next/static/chunks/09md0.811p4qk.js","/_next/static/chunks/0jjo8hz~ewue4.js","/_next/static/chunks/084k0pvimg.lq.js","/_next/static/chunks/0a~e7k..h6jfc.js","/_next/static/chunks/0d1e9m2ig9v3v.js","/_next/static/chunks/0dzini03ngxm2.js","/_next/static/chunks/0rizq9ux3s1w3.js","/_next/static/chunks/139o5utivfajl.js","/_next/static/chunks/0i-f~c821e7uk.js","/_next/static/chunks/0z7avafhgjcyr.js"],"EpisodeTranscript"] 3c:["$","svg",null,{"className":"w-4 h-4","fill":"none","stroke":"currentColor","viewBox":"0 0 24 24","children":["$","path",null,{"strokeLinecap":"round","strokeLinejoin":"round","strokeWidth":2,"d":"M8 7V3m8 4V3m-9 8h10M5 21h14a2 2 0 002-2V7a2 2 0 00-2-2H5a2 2 0 00-2 2v12a2 2 0 002 2z"}]}] 3d:["$","time",null,{"dateTime":"2026-04-21T05:32:29.000Z","children":"Tue Apr 21 2026"}] 44:T523,

Tuesday April 21, 2026

In this episode, we delve into Eli Lilly's strategic acquisition of Boston-based biotech firm Kelonia Therapeutics for $7 billion, marking a significant expansion in Massachusetts' thriving biotech sector. This deal highlights the potential of Kelonia's innovative cell therapies for blood cancers, including a promising treatment for multiple myeloma. Meanwhile, Boston's sports scene is buzzing with the Bruins seeking redemption against the Buffalo Sabres in the first round of the playoffs after a surprising comeback loss. On the baseball diamond, the Red Sox evened their series against Detroit and gear up for a key matchup with the Yankees at Fenway. The Celtics also look to continue their dominance over the 76ers at the Garden, with stars Jaylen Brown and Jayson Tatum leading the charge.

In other news, we discuss a groundbreaking study on reversing hair loss using sugar, and Connie Ballmer's $80 million donation to NPR aimed at digital innovation. We also touch on the latest movements in the crypto markets and explore scientific insights into why birds were the only dinosaurs to survive the mass extinction event. Join us for these stories and more as we explore the latest developments in Boston and beyond.

@sunnymorningsmedia

Eli Lilly's $7B Boston Biotech Buy, Bruins Seek Redemption